NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,897 | +3.5% | 11,580 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,661 | -45.5% | 11,580 | -33.3% | 0.00% | -50.0% |
| Q1 2023 | $12,211 | -68.9% | 17,370 | 0.0% | 0.00% | -71.4% |
| Q4 2022 | $39,256 | -29.9% | 17,370 | 0.0% | 0.01% | -41.7% |
| Q3 2022 | $56,000 | -15.2% | 17,370 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $66,000 | -29.8% | 17,370 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $94,000 | -60.0% | 17,370 | 0.0% | 0.02% | -61.0% |
| Q4 2021 | $235,000 | -24.7% | 17,370 | 0.0% | 0.04% | -18.0% |
| Q3 2021 | $312,000 | +4.7% | 17,370 | 0.0% | 0.05% | +6.4% |
| Q2 2021 | $298,000 | -33.3% | 17,370 | -25.0% | 0.05% | -39.7% |
| Q1 2021 | $447,000 | +13.5% | 23,160 | 0.0% | 0.08% | +27.9% |
| Q4 2020 | $394,000 | +2.6% | 23,160 | 0.0% | 0.06% | -17.6% |
| Q3 2020 | $384,000 | – | 23,160 | +115700.0% | 0.07% | – |
| Q2 2020 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |